Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) reported Other Non-Current Liabilities of $82.0 million for Q4 2025, down 24.07% on a YoY basis from $108.0 million in Q4 2024, and down 12.77% quarter-over-quarter from $94.0 million in Q2 2025.
Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Other Non-Current Liabilities for 15 years, with the latest figure at $82.0 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Liabilities fell 24.07% year-over-year to $82.0 million; the trailing twelve-month figure through Dec 2025 stood at $82.0 million (down 24.07% YoY), and the FY2025 full-year result was $82.0 million, down 24.07% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $82.0 million, down from $94.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $243.0 million in Q4 2022, with the low at $35.0 million in Q4 2021.
- Historically, Other Non-Current Liabilities has averaged $135.3 million across 5 years, with a median of $108.0 million in 2024.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities plunged 88.1% — and 2022, when it soared 594.29%.
- Smith & Nephew's Other Non-Current Liabilities stood at $35.0 million in 2021, then soared by 594.29% to $243.0 million in 2022, then retreated by 4.12% to $233.0 million in 2023, then slumped by 53.65% to $108.0 million in 2024, then decreased by 24.07% to $82.0 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $82.0 million (Q4 2025), $94.0 million (Q2 2025), and $108.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.00 Mn |
| Jun 28, 2025 | 94.00 Mn |
| Dec 31, 2024 | 108.00 Mn |
| Jun 29, 2024 | 152.00 Mn |
| Dec 31, 2023 | 233.00 Mn |
| Dec 31, 2022 | 243.00 Mn |
| Dec 31, 2021 | 35.00 Mn |
| Dec 31, 2020 | 294.00 Mn |
| Jun 30, 2020 | 236.00 Mn |
| Dec 31, 2019 | 214.00 Mn |
| Jun 29, 2019 | 143.00 Mn |
| Dec 31, 2018 | 153.00 Mn |
| Jun 30, 2018 | 137.00 Mn |
| Dec 31, 2017 | 97.00 Mn |
| Dec 31, 2016 | 134.00 Mn |
| Dec 31, 2015 | 193.00 Mn |
| Jun 30, 2015 | 79.00 Mn |
| Dec 31, 2014 | 67.00 Mn |
| Sep 30, 2014 | 83.00 Mn |
| Jun 28, 2014 | 112.00 Mn |